Jung Seung-Ryoung, Seo Jong Bae, Deng Yi, Asbury Charles L, Hille Bertil, Koh Duk-Su
Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195.
Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195 Department of Physics, Pohang University of Science and Technology, Pohang, Kyungbuk, 790-784, Republic of Korea
J Gen Physiol. 2016 Mar;147(3):255-71. doi: 10.1085/jgp.201511477.
Activated Gq protein-coupled receptors (GqPCRs) can be desensitized by phosphorylation and β-arrestin binding. The kinetics and individual contributions of these two mechanisms to receptor desensitization have not been fully distinguished. Here, we describe the shut off of protease-activated receptor 2 (PAR2). PAR2 activates Gq and phospholipase C (PLC) to hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol and inositol trisphosphate (IP3). We used fluorescent protein-tagged optical probes to monitor several consequences of PAR2 signaling, including PIP2 depletion and β-arrestin translocation in real time. During continuous activation of PAR2, PIP2 was depleted transiently and then restored within a few minutes, indicating fast receptor activation followed by desensitization. Knockdown of β-arrestin 1 and 2 using siRNA diminished the desensitization, slowing PIP2 restoration significantly and even adding a delayed secondary phase of further PIP2 depletion. These effects of β-arrestin knockdown on PIP2 recovery were prevented when serine/threonine phosphatases that dephosphorylate GPCRs were inhibited. Thus, PAR2 may continuously regain its activity via dephosphorylation when there is insufficient β-arrestin to trap phosphorylated receptors. Similarly, blockers of protein kinase C (PKC) and G protein-coupled receptor kinase potentiated the PIP2 depletion. In contrast, an activator of PKC inhibited receptor activation, presumably by augmenting phosphorylation of PAR2. Our interpretations were strengthened by modeling. Simulations supported the conclusions that phosphorylation of PAR2 by protein kinases initiates receptor desensitization and that recruited β-arrestin traps the phosphorylated state of the receptor, protecting it from phosphatases. Speculative thinking suggested a sequestration of phosphatidylinositol 4-phosphate 5 kinase (PIP5K) to the plasma membrane by β-arrestin to explain why knockdown of β-arrestin led to secondary depletion of PIP2. Indeed, artificial recruitment of PIP5K removed the secondary loss of PIP2 completely. Altogether, our experimental and theoretical approaches demonstrate roles and dynamics of the protein kinases, β-arrestin, and PIP5K in the desensitization of PAR2.
活化的Gq蛋白偶联受体(GqPCRs)可通过磷酸化和β-抑制蛋白结合而脱敏。这两种机制对受体脱敏的动力学及各自作用尚未完全区分清楚。在此,我们描述了蛋白酶激活受体2(PAR2)的失敏过程。PAR2激活Gq和磷脂酶C(PLC),将磷脂酰肌醇4,5-二磷酸(PIP2)水解为二酰甘油和肌醇三磷酸(IP3)。我们使用荧光蛋白标记的光学探针实时监测PAR2信号传导的几种结果,包括PIP2耗竭和β-抑制蛋白易位。在PAR2持续激活过程中,PIP2短暂耗竭,然后在几分钟内恢复,表明受体快速激活后发生脱敏。使用小干扰RNA(siRNA)敲低β-抑制蛋白1和2可减少脱敏,显著减缓PIP2恢复,甚至增加进一步PIP2耗竭的延迟第二阶段。当抑制使GPCRs去磷酸化的丝氨酸/苏氨酸磷酸酶时,β-抑制蛋白敲低对PIP2恢复的这些影响被阻止。因此,当没有足够的β-抑制蛋白捕获磷酸化受体时,PAR2可能通过去磷酸化持续恢复其活性。同样,蛋白激酶C(PKC)和G蛋白偶联受体激酶的阻滞剂增强了PIP2耗竭。相反,PKC激活剂抑制受体激活,可能是通过增强PAR2的磷酸化。我们的解释通过建模得到了加强。模拟结果支持以下结论:蛋白激酶对PAR2的磷酸化启动受体脱敏,募集的β-抑制蛋白捕获受体的磷酸化状态,使其免受磷酸酶作用。推测性思考表明β-抑制蛋白将磷脂酰肌醇4-磷酸5激酶(PIP5K)隔离到质膜,以解释为什么β-抑制蛋白敲低会导致PIP2的继发性耗竭。事实上,人工募集PIP5K完全消除了PIP2的继发性损失。总之,我们的实验和理论方法证明了蛋白激酶、β-抑制蛋白和PIP5K在PAR2脱敏中的作用和动态变化。